Recently, higher levels of carnitines were detected in prostate cancer tissue with presence of the gene fusion TMPRSS2-ERG (transmembrane protease, serine 2—ETS-related gene), a marker associated with shorter recurrence-free survival and cancer specific death [48]. The gene discussed is ERG; the disease is prostate cancer.